{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T15:44:22Z","timestamp":1784735062865,"version":"3.55.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,20]],"date-time":"2025-12-20T00:00:00Z","timestamp":1766188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T00:00:00Z","timestamp":1769731200000},"content-version":"vor","delay-in-days":41,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Yunnan Major Scientific and Technological Projects","award":["(202202AG050013, 202302AA310044, 202405AJ310002, and 202502AA310025"],"award-info":[{"award-number":["(202202AG050013, 202302AA310044, 202405AJ310002, and 202502AA310025"]}]},{"name":"Yunnan Major Scientific and Technological Projects","award":["(202202AG050013, 202302AA310044, 202405AJ310002, and 202502AA310025"],"award-info":[{"award-number":["(202202AG050013, 202302AA310044, 202405AJ310002, and 202502AA310025"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Microbiol"],"DOI":"10.1186\/s12866-025-04601-4","type":"journal-article","created":{"date-parts":[[2025,12,20]],"date-time":"2025-12-20T02:03:24Z","timestamp":1766196204000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["A novel one-tube nested fluorescence melting curve analysis for rapid detection of drug-resistant Mycobacterium tuberculosis"],"prefix":"10.1186","volume":"26","author":[{"given":"Yingchao","family":"Chang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaowen","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaofei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tingting","family":"Diao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cuixian","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinlin","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yungui","family":"Tu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongji","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pei","family":"Lei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueshan","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,20]]},"reference":[{"key":"4601_CR1","volume-title":"Global tuberculosis report 2024","author":"World Health Organization","year":"2024","unstructured":"World Health Organization. Global tuberculosis report 2024. Geneva: World Health Organization; 2024."},{"key":"4601_CR2","volume-title":"WHO consolidated guidelines on tuberculosis, module 4: treatment-drug-resistant tuberculosis treatment, 2022 update","author":"World Health Organization","year":"2022","unstructured":"World Health Organization. WHO consolidated guidelines on tuberculosis, module 4: treatment-drug-resistant tuberculosis treatment, 2022 update. Geneva: World Health Organization; 2022."},{"key":"4601_CR3","doi-asserted-by":"publisher","first-page":"95003","DOI":"10.7554\/eLife.96190.3","volume":"13","author":"M Zohaib Ali","year":"2024","unstructured":"Zohaib Ali M, Dutt TS, MacNeill A, Walz A, Pearce C, Lam H, et al. A modified BPaL regimen for tuberculosis treatment replaces linezolid with inhaled spectinamides. eLife. 2024;13:95003.","journal-title":"eLife"},{"issue":"3","key":"4601_CR4","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1093\/cid\/ciac528","volume":"76","author":"C Padmapriyadarsini","year":"2023","unstructured":"Padmapriyadarsini C, Vohra V, Bhatnagar A, Solanki R, Sridhar R, Anande L, et al. Bedaquiline, Delamanid, Linezolid, and Clofazimine for treatment of Pre-extensively Drug-Resistant tuberculosis. Clin Infect Dis. 2023;76(3):938\u201346.","journal-title":"Clin Infect Dis"},{"key":"4601_CR5","unstructured":"endTB. endTB clinical trial results. Available at: https:\/\/endtb.org\/endtb-clinical-trial-results. endTB. Accessed 5 Nov2023."},{"issue":"1","key":"4601_CR6","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1186\/s13063-023-07701-6","volume":"24","author":"SB Patil","year":"2023","unstructured":"Patil SB, Tamirat M, Khazhidinov K, Ardizzoni E, Atger M, Austin A, et al. Evaluating newly approved drugs in combination regimens for multidrug-resistant tuberculosis with fluoroquinolone resistance (endTB-Q): study protocol for a multi-country randomized controlled trial. Trials. 2023;24(1):773.","journal-title":"Trials"},{"issue":"8","key":"4601_CR7","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.1093\/cid\/ciac176","volume":"75","author":"H Huerga","year":"2022","unstructured":"Huerga H, Khan U, Bastard M, Mitnick CD, Lachenal N, Khan PY, et al. Safety and effectiveness outcomes from a 14-country cohort of patients with multi-drug resistant tuberculosis treated concomitantly with bedaquiline, delamanid, and other second-line drugs. Clin Infect Dis. 2022;75(8):1307\u201314.","journal-title":"Clin Infect Dis"},{"issue":"6","key":"4601_CR8","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24065202","volume":"24","author":"SSR Alsayed","year":"2023","unstructured":"Alsayed SSR, Gunosewoyo H. Tuberculosis: pathogenesis, current treatment regimens and new drug targets. Int J Mol Sci. 2023;24(6):5202.","journal-title":"Int J Mol Sci"},{"issue":"3","key":"4601_CR9","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1016\/j.cmi.2020.08.030","volume":"27","author":"I Mokrousov","year":"2021","unstructured":"Mokrousov I, Akhmedova G, Molchanov V, Fundovnaya E, Kozlova E, Ostankova Y, et al. Frequent acquisition of bedaquiline resistance by epidemic extensively drug-resistant Mycobacterium tuberculosis strains in Russia during long-term treatment. Clin Microbiol Infect. 2021;27(3):478\u201380.","journal-title":"Clin Microbiol Infect"},{"key":"4601_CR10","doi-asserted-by":"publisher","first-page":"794","DOI":"10.3389\/fmicb.2019.00794","volume":"10","author":"TNA Nguyen","year":"2019","unstructured":"Nguyen TNA, Anton-Le Berre V, Ba\u00f1uls A-L, Nguyen TVA. Molecular diagnosis of drug-resistant tuberculosis; a literature review. Front Microbiol. 2019;10:794.","journal-title":"Front Microbiol"},{"issue":"7","key":"4601_CR11","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1136\/thorax-2023-220202","volume":"79","author":"SN Danchuk","year":"2024","unstructured":"Danchuk SN, Solomon OE, Kohl TA, Dreyer V, Barilar I, Utpatel C, et al. Challenging the gold standard: the limitations of molecular assays for detection ofMycobacterium tuberculosisheteroresistance. Thorax. 2024;79(7):670\u20135.","journal-title":"Thorax"},{"key":"4601_CR12","unstructured":"World Health Organization. WHO consolidated guidelines on tuberculosis. Module 3: diagnosis \u2013 rapid diagnostics for tuberculosis detection, third edition. Geneva: World Health Organization; 2024."},{"key":"4601_CR13","volume-title":"WHO consolidated guidelines on tuberculosis: module 3:diagnosis:rapid diagnostics for tuberculosis detection, 2021 update","author":"World Health Organization","year":"2021","unstructured":"World Health Organization. WHO consolidated guidelines on tuberculosis: module 3:diagnosis:rapid diagnostics for tuberculosis detection, 2021 update. Geneva: World Health Organization; 2021."},{"issue":"1","key":"4601_CR14","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1186\/s12941-024-00741-z","volume":"23","author":"L Vasiliauskait\u0117","year":"2024","unstructured":"Vasiliauskait\u0117 L, Baku\u0142a Z, Vasiliauskien\u0117 E, Bakonyt\u0117 D, Decewicz P, Dziurzy\u0144ski M, et al. Detection of multidrug-resistance in Mycobacterium tuberculosis by phenotype- and molecular-based assays. Ann Clin Microbiol Antimicrob. 2024;23(1):81.","journal-title":"Ann Clin Microbiol Antimicrob"},{"issue":"4","key":"4601_CR15","doi-asserted-by":"publisher","first-page":"2501","DOI":"10.1007\/s11033-020-05331-8","volume":"47","author":"N Chumpa","year":"2020","unstructured":"Chumpa N, Kawkitinarong K, Rotcheewaphan S, Sawatpanich A, Petsong S, Tumwasorn S, et al. Evaluation of Anyplex\u2122 II MTB\/MDR kit\u2019s performance to rapidly detect Isoniazid and rifampicin resistant Mycobacterium tuberculosis from various clinical specimens. Mol Biol Rep. 2020;47(4):2501\u20138.","journal-title":"Mol Biol Rep"},{"issue":"10","key":"4601_CR16","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.1016\/S1473-3099(24)00263-9","volume":"24","author":"TC Schwab","year":"2024","unstructured":"Schwab TC, Perrig L, G\u00f6ller PC, la Guebely De Hoz FF, Lahousse AP, Minder B, et al. Targeted next-generation sequencing to diagnose drug-resistant tuberculosis: a systematic review and meta-analysis. Lancet Infect Dis. 2024;24(10):1162\u201376.","journal-title":"Lancet Infect Dis"},{"issue":"12","key":"4601_CR17","doi-asserted-by":"publisher","first-page":"2782","DOI":"10.3390\/pharmaceutics15122782","volume":"15","author":"D Hazra","year":"2023","unstructured":"Hazra D, Lam C, Chawla K, Sintchenko V, Dhyani VS, Venkatesh BT. Impact of whole-genome sequencing of Mycobacterium tuberculosis on treatment outcomes for MDR-TB\/XDR-TB: a systematic review. Pharmaceutics. 2023;15(12):2782.","journal-title":"Pharmaceutics"},{"issue":"9","key":"4601_CR18","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1038\/s41579-019-0214-5","volume":"17","author":"CJ Meehan","year":"2019","unstructured":"Meehan CJ, Goig GA, Kohl TA, Verboven L, Dippenaar A, Ezewudo M, et al. Whole genome sequencing of Mycobacterium tuberculosis: current standards and open issues. Nat Rev Microbiol. 2019;17(9):533\u201345.","journal-title":"Nat Rev Microbiol"},{"issue":"2","key":"4601_CR19","doi-asserted-by":"publisher","first-page":"e01239","DOI":"10.1128\/JCM.01239-17","volume":"56","author":"B Liang","year":"2018","unstructured":"Liang B, Tan Y, Li Z, Tian X, Du C, Li H, et al. Highly sensitive detection of Isoniazid heteroresistance in Mycobacterium tuberculosis by deepmelt assay. J Clin Microbiol. 2018;56(2):e01239-17.","journal-title":"J Clin Microbiol"},{"issue":"9","key":"4601_CR20","doi-asserted-by":"publisher","first-page":"3132","DOI":"10.1128\/JCM.02046-10","volume":"49","author":"T Luo","year":"2011","unstructured":"Luo T, Jiang L, Sun W, Fu G, Mei J, Gao Q. Multiplex real-time PCR melting curve assay to detect drug-resistant mutations of Mycobacterium tuberculosis. J Clin Microbiol. 2011;49(9):3132\u20138.","journal-title":"J Clin Microbiol"},{"key":"4601_CR21","volume":"7","author":"KL Chin","year":"2024","unstructured":"Chin KL, Anibarro L, Chang ZY, Palasuberniam P, Mustapha ZA, Sarmiento ME, et al. Impacts of MDR\/XDR-TB on the global tuberculosis epidemic: challenges and opportunities. Curr Res Microb Sci. 2024;7:100295.","journal-title":"Curr Res Microb Sci"},{"issue":"4","key":"4601_CR22","doi-asserted-by":"publisher","first-page":"e122","DOI":"10.1016\/S1473-3099(22)00875-1","volume":"23","author":"J Dom\u00ednguez","year":"2023","unstructured":"Dom\u00ednguez J, Boeree MJ, Cambau E, Chesov D, Conradie F, Cox V, et al. Clinical implications of molecular drug resistance testing for Mycobacterium tuberculosis: a 2023 TBnet\/RESIST-TB consensus statement. Lancet Infect Dis. 2023;23(4):e122\u201337.","journal-title":"Lancet Infect Dis"},{"issue":"6","key":"4601_CR23","doi-asserted-by":"publisher","first-page":"2371","DOI":"10.1007\/s15010-024-02295-w","volume":"52","author":"L Xie","year":"2024","unstructured":"Xie L, Zhu X-Y, Xu L, Xu X-X, Ruan Z-F, Huang M-X, et al. Accurate and affordable detection of rifampicin and Isoniazid resistance in tuberculosis sputum specimens by multiplex PCR-multiple probes melting analysis. Infection. 2024;52(6):2371\u201398.","journal-title":"Infection"},{"key":"4601_CR24","doi-asserted-by":"publisher","first-page":"119701","DOI":"10.1016\/j.cca.2024.119701","volume":"559","author":"DA Wulandari","year":"2024","unstructured":"Wulandari DA, Hartati YW, Ibrahim AU, Pitaloka DAE. Irkham. Multidrug-resistant tuberculosis. Clin Chim Acta. 2024;559:119701.","journal-title":"Clin Chim Acta"},{"issue":"3","key":"4601_CR25","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2021.106385","volume":"58","author":"P Chaiyachat","year":"2021","unstructured":"Chaiyachat P, Chaiprasert A, Nonghanphithak D, Smithtikarn S, Kamolwat P, Pungrassami P, et al. Whole-genome analysis of drug-resistant Mycobacterium tuberculosis reveals novel mutations associated with fluoroquinolone resistance. Int J Antimicrob Agents. 2021;58(3):106385.","journal-title":"Int J Antimicrob Agents"},{"issue":"7","key":"4601_CR26","doi-asserted-by":"publisher","first-page":"1901","DOI":"10.1093\/jac\/dkx094","volume":"72","author":"DV Zimenkov","year":"2017","unstructured":"Zimenkov DV, Nosova EY, Kulagina EV, Antonova OV, Arslanbaeva LR, Isakova AI, et al. Examination of bedaquiline- and linezolid-resistant Mycobacterium tuberculosis isolates from the Moscow region. J Antimicrob Chemother. 2017;72(7):1901\u20136.","journal-title":"J Antimicrob Chemother"},{"key":"4601_CR27","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.jviromet.2018.09.010","volume":"262","author":"P Liu","year":"2018","unstructured":"Liu P, Lu L, Xu M, Zhong H, Jia R, Su L, et al. A novel multiplex PCR for virus detection by melting curve analysis. J Virol Methods. 2018;262:56\u201360.","journal-title":"J Virol Methods"},{"issue":"1","key":"4601_CR28","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1128\/JCM.01771-16","volume":"55","author":"S Chakravorty","year":"2017","unstructured":"Chakravorty S, Roh SS, Glass J, Smith LE, Simmons AM, Lund K, et al. Detection of isoniazid-, fluoroquinolone-, amikacin-, and kanamycin-resistant tuberculosis in an automated, multiplexed 10-color assay suitable for point-of-care use. J Clin Microbiol. 2017;55(1):183\u201398.","journal-title":"J Clin Microbiol"},{"issue":"4","key":"4601_CR29","doi-asserted-by":"publisher","first-page":"00812","DOI":"10.1128\/mBio.00812-17","volume":"8","author":"S Chakravorty","year":"2017","unstructured":"Chakravorty S, Simmons AM, Rowneki M, Parmar H, Cao Y, Ryan J, et al. The new Xpert MTB\/RIF ultra: improving detection of Mycobacterium tuberculosis and resistance to Rifampin in an assay suitable for Point-of-Care testing. mBio. 2017;8(4):00812\u201317.","journal-title":"mBio"},{"issue":"5","key":"4601_CR30","doi-asserted-by":"publisher","first-page":"1644","DOI":"10.1128\/JCM.03395-13","volume":"52","author":"S Hu","year":"2014","unstructured":"Hu S, Li G, Li H, Liu X, Niu J, Quan S, et al. Rapid detection of isoniazid resistance in Mycobacterium tuberculosis isolates by use of real-time-PCR-based melting curve analysis. J Clin Microbiol. 2014;52(5):1644\u201352.","journal-title":"J Clin Microbiol"},{"issue":"1","key":"4601_CR31","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s12879-018-3638-z","volume":"19","author":"NM Al-Mutairi","year":"2019","unstructured":"Al-Mutairi NM, Ahmad S, Mokaddas E, Eldeen HS, Joseph S. Occurrence of disputed RpoB mutations among Mycobacterium tuberculosis isolates phenotypically susceptible to rifampicin in a country with a low incidence of multidrug-resistant tuberculosis. BMC Infect Dis. 2019;19(1):3.","journal-title":"BMC Infect Dis"},{"issue":"8","key":"4601_CR32","doi-asserted-by":"publisher","first-page":"2641","DOI":"10.1128\/JCM.02741-12","volume":"51","author":"L Rigouts","year":"2013","unstructured":"Rigouts L, Gumusboga M, de Rijk WB, Nduwamahoro E, Uwizeye C, de Jong B, et al. Rifampin resistance missed in automated liquid culture system for Mycobacterium tuberculosis isolates with specific rpoB mutations. J Clin Microbiol. 2013;51(8):2641\u20135.","journal-title":"J Clin Microbiol"},{"issue":"10","key":"4601_CR33","doi-asserted-by":"publisher","first-page":"3722","DOI":"10.1128\/JCM.05314-11","volume":"49","author":"R Moure","year":"2011","unstructured":"Moure R, Mart\u00edn R, Alcaide F. Silent mutation in RpoB detected from clinical samples with rifampin-susceptible Mycobacterium tuberculosis. J Clin Microbiol. 2011;49(10):3722.","journal-title":"J Clin Microbiol"},{"issue":"7","key":"4601_CR34","doi-asserted-by":"publisher","first-page":"2688","DOI":"10.1128\/JCM.00659-11","volume":"49","author":"M Alonso","year":"2011","unstructured":"Alonso M, Palacios JJ, Herranz M, Penedo A, Men\u00e9ndez A, Bouza E, et al. Isolation of Mycobacterium tuberculosis strains with a silent mutation in rpoB leading to potential misassignment of resistance category. J Clin Microbiol. 2011;49(7):2688\u201390.","journal-title":"J Clin Microbiol"},{"key":"4601_CR35","doi-asserted-by":"publisher","DOI":"10.1016\/j.jctube.2023.100410","volume":"34","author":"Z Bonsa","year":"2024","unstructured":"Bonsa Z, Tadesse M, Balay G, Kebede W, Abebe G. Discordance between genotypic and phenotypic methods for the detection of rifampicin and isoniazid resistant Mycobacterium tuberculosis and the correlation with patient treatment outcomes. J Clin Tuberc Other Mycobact Dis. 2024;34:100410.","journal-title":"J Clin Tuberc Other Mycobact Dis"},{"issue":"9","key":"4601_CR36","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1016\/j.cmi.2023.07.013","volume":"30","author":"I Motta","year":"2024","unstructured":"Motta I, Boeree M, Chesov D, Dheda K, G\u00fcnther G, Horsburgh CR, et al. Recent advances in the treatment of tuberculosis. Clin Microbiol Infect. 2024;30(9):1107\u201314.","journal-title":"Clin Microbiol Infect"},{"key":"4601_CR37","first-page":"57311","volume":"16","author":"S Yadav","year":"2024","unstructured":"Yadav S, Rawal G, Jeyaraman M, Jeyaraman N. Advancements in tuberculosis diagnostics: a comprehensive review of the critical role and future prospects of Xpert MTB\/RIF ultra technology. Cureus. 2024;16:57311.","journal-title":"Cureus"},{"issue":"1","key":"4601_CR38","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1186\/s12879-024-09976-9","volume":"24","author":"J Zhou","year":"2024","unstructured":"Zhou J, Li J, Hu Y, Li S. Epidemiological characteristics, diagnosis and treatment effect of rifampicin-resistant pulmonary tuberculosis (RR-PTB) in Guizhou Province. BMC Infect Dis. 2024;24(1):1058.","journal-title":"BMC Infect Dis"},{"issue":"8","key":"4601_CR39","doi-asserted-by":"publisher","first-page":"4378","DOI":"10.21037\/jtd-20-1928","volume":"12","author":"Z Yang","year":"2020","unstructured":"Yang Z, Wu J, Ye F, Zhu B, Guan W, Huang J, et al. Expert consensus-based laboratory testing of SARS-CoV-2. J Thorac Dis. 2020;12(8):4378\u201390.","journal-title":"J Thorac Dis"}],"container-title":["BMC Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12866-025-04601-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12866-025-04601-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12866-025-04601-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T13:19:09Z","timestamp":1769779149000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12866-025-04601-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,20]]},"references-count":39,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4601"],"URL":"https:\/\/doi.org\/10.1186\/s12866-025-04601-4","relation":{},"ISSN":["1471-2180"],"issn-type":[{"value":"1471-2180","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,20]]},"assertion":[{"value":"5 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study adhered to the tenets of the Declaration of Helsinki and was approved by the Medical Ethics Committee of Kunming University of Science and Technology, reference number KUST-MEC-097. All participants provided written informed consent for sample collection and subsequent analysis.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"72"}}